Author: OurCrowd

[Remilk in PR Newswire] Historic achievement: Remilk becomes first company to secure regulatory approval for non-animal milk protein in Israel

TEL AVIV, Israel, April 27, 2023 /PRNewswire/ — Remilk, a global leader in the development and production of animal-free dairy protein has received a first-of-its-kind approval from the Israeli Ministry of Health (MOH). This historic regulatory event clears a path for the marketing and sale of non-animal dairy products made with Remilk for Israeli consumers. Read...

Read More

[Scopio in PR Newswire] Study Reveals Faster Turnaround Time in Clinical Laboratory With Scopio Labs’ Remote Digital Morphology

TEL AVIV, Israel, April 27, 2023 /PRNewswire/ — Scopio Labs today announced the publication of a new study that examines the impact of implementing remote* digital microscopy for peripheral blood smear (PBS) analysis. Conducted by Tel Aviv Sourasky Medical Center (TASMC) and published in Applied Clinical Informatics, the study found that the application of Scopio’s digital imaging and analysis system significantly reduces laboratory turnaround time (TAT) for PBS review, as compared to TASMC’s previous digital morphology workflow. Read more...

Read More